Taken together, our work indicates that diffusion MRI may detect early microstructural changes that reflect alpha-synuclein-induced brain changes already in preclinical stages of PD and can be used to monitor brain pathology spreading until major neurodegeneration occurs. This evidence concerns the gene SNCA and Parkinson disease.